Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sulforaphane-rich broccoli sprout extract is a botanical preparation containing high levels of glucoraphanin and its active metabolite, sulforaphane. Sulforaphane is a potent inducer of the **Nuclear factor erythroid 2-related factor 2 (Nrf2)** pathway, which orchestrates the cellular antioxidant response and reduces oxidative stress and neuroinflammation. This extract has been evaluated in clinical trials, particularly by researchers like Dr. Andrew Zimmerman, for its potential to improve core behavioral symptoms in individuals with **autism spectrum disorder (ASD)**. The mechanism is thought to involve the upregulation of cytoprotective genes that address the physiological abnormalities often associated with autism, such as mitochondrial dysfunction and redox imbalance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sulforaphane-rich broccoli sprout extract.